Teva Pharmaceutical Shares Plunge After Quarterly Loss and 2018 Outlook Warning - WSJ
Teva Reports Third Quarter 2023 Financial Results and Increases Revenue Guidance
Teva profit plummets, stock slides | Ctech
Teva Pharmaceutical Industries Third Quarter 2022 Earnings: Misses Expectations
Teva shares climb as third-quarter sales top estimates - MarketWatch
Teva Pharmaceutical Industries (NYSE:TEVA) Sees Large Volume Increase on Analyst Upgrade - MarketBeat
Teva Seeking to Break Its Streak of Post-Earnings Stock Losses - Bloomberg
Teva Pharmaceuticals on X: "On Wednesday, November 8, tune in to our live Q3 2023 earnings call with CEO Richard Francis and the Teva leadership team. Save the date: https://t.co/o7w2CSmxZB #QuarterlyResults #Q3Results #
Teva Pharmaceutical Statistics, Facts, Revenue, Subsidiaries
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) Revenue Growth
Teva Pharmaceutical Industries Ltd. - Financials - Quarterly Results
Teva Pharmaceutical Industries Limited 2022 Q4 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceuticals (TEVA) Q2 2020 earnings: Reaffirms FY20 outlook | AlphaStreet
Teva Reports Fourth Quarter and Full Year 2022 Financial Results | Business Wire
Teva CEO Richard Francis on Q2 earnings beat
TEVA | Market Realist
Teva's Q3 triumph: 7% revenue surge propelled by Austedo and Ajovy
Teva Pharmaceuticals Q4 2016 Earnings
Teva Tops Q2 Earnings Forecast, Holds 2019 Guidance; CFO Departure Hits Shares - TheStreet
Teva earnings preview: Opioid suits are 'key' - MarketWatch
Infographic: Teva Pharmaceuticals (TEVA) Q1 2021 earnings results | AlphaStreet
Teva to cut up to 1,700 jobs in streamlining plan — report | The Times of Israel
Drugmaker Teva does not see big impact on business from Israel-Hamas war | Reuters
Teva Pharmaceutical Industries Limited 2023 Q3 - Results - Earnings Call Presentation (NYSE:TEVA) | Seeking Alpha
Teva, armed with 2 recent launches, raises revenue guidance
